Published in AIDS Weekly, February 21st, 2000
"HAART has been demonstrated to have a beneficial effect on the clinical, immunologic and virologic course of HIV infected individuals. However, the relationship between HAART use and the course of HPV-associated disease has not been rigorously assessed," the Johns Hopkins scientists said.
H. Minkoff and others at the university presented their findings in the study entitled "Effect of Highly Active...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.